Is it safe for a 72-year-old patient taking aspirin to undergo an asymptomatic screening colonoscopy?

Aspirin and Screening Colonoscopy in a 72-Year-Old

Yes, it is safe for a 72-year-old patient on aspirin to undergo screening colonoscopy, and aspirin should be continued throughout the procedure. The evidence consistently demonstrates that continuing aspirin during colonoscopy, even with polypectomy, poses minimal bleeding risk that does not outweigh the cardiovascular and thromboembolic risks of discontinuation 1.

Age-Appropriate Screening Context

• This patient falls within the recommended screening age range where the decision to screen should be individualized based on overall health and prior screening history 2.
• The USPSTF recommends that screening decisions for adults aged 76-85 years should be individualized, but at age 72, screening remains appropriate if the patient has reasonable life expectancy and is in adequate health 2.

Aspirin Management During Colonoscopy

Continue Aspirin - The Evidence-Based Approach

• Aspirin continuation is the standard of care for patients undergoing colonoscopy, including those requiring polypectomy 1.
• The rate of postpolypectomy bleeding in patients who continue aspirin is not significantly different from those not taking antiplatelet medications 1.
• The overall risk of postpolypectomy bleeding remains less than 0.5% even when aspirin is continued 1.

Bleeding Risk Considerations

• While one retrospective study showed aspirin users had increased bleeding risk (OR=6.72), this must be contextualized against the thromboembolic risks of aspirin discontinuation 3.
• The primary risk factors for postpolypectomy bleeding are large polyp size and use of warfarin or thienopyridines, not aspirin 1.
• Aspirin's antiplatelet effects are far less potent than thienopyridines (clopidogrel, prasugrel), which carry a 2.4% delayed bleeding risk 1.

Clinical Practice Reality

• Less than half (43.5%) of U.S. endoscopy units routinely continue aspirin before colonoscopy, despite evidence supporting continuation 4.
• The most common reasons for inappropriate discontinuation include unfounded concern about bleeding (62%), perceived minimal downside to stopping (38%), and inertia to change old policies (20%) 4.
• Gastroenterology societies have made firm statements that aspirin is safe to continue, yet practice patterns lag behind evidence 4.

Key Safety Considerations

Cardiovascular Risk of Stopping Aspirin

• If aspirin is being used for secondary prevention (history of MI, stroke, or established cardiovascular disease), stopping it creates significant thromboembolic risk that far exceeds any bleeding risk from colonoscopy 1.
• Even for primary prevention, the decision to interrupt aspirin requires careful consideration of the patient's cardiovascular risk profile 5.

Procedural Approach

• No special precautions or modifications to standard colonoscopy technique are required for patients on aspirin 1.
• Standard bowel preparation should proceed as planned 2.
• If large polyps (>2 cm) are encountered, the endoscopist may use enhanced hemostatic techniques, but aspirin continuation remains appropriate 1.

Common Pitfalls to Avoid

• Do not routinely discontinue aspirin based on outdated protocols or unfounded bleeding concerns 4.
• Do not confuse aspirin with other anticoagulants like warfarin or direct oral anticoagulants, which require different management strategies 1.
• Do not assume NSAIDs carry the same risk profile as aspirin; while NSAIDs were not associated with increased bleeding in some studies, they are distinct medications 3.

Practical Algorithm

For this 72-year-old patient on aspirin:

1. Continue aspirin through the colonoscopy procedure 1.
2. Proceed with standard bowel preparation 2.
3. Perform colonoscopy with or without polypectomy as clinically indicated 1.
4. No bridging therapy or special monitoring is required 1.
5. Resume normal activities per standard post-colonoscopy instructions 2.